Massachusetts

Blueprint Medicines Announces European Commission Approval of AYVAKYT® (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumors

CAMBRIDGE, Mass., Sept. 25, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that the…
Continue Reading »
Massachusetts

Amherst, Wesleyan Presidents Lead Coalition Of Higher Ed Leaders In Urging U.S. Department Of Education To Abandon Civil Rights Investigation Of Princeton University

AMHERST, Mass. and MIDDLETOWN, Conn., Sept. 24, 2020 /PRNewswire/ -- Today, more than 80 college and university leaders have signed onto a statement co-authored by Presidents Biddy Martin of Amherst…
Continue Reading »
Massachusetts

Fish & Richardson Named 2020 Intellectual Property Boutique Firm of the Year by LMG Life Sciences; Wins Hatch-Waxman Impact Case of the Year

BOSTON, Sept. 24, 2020 /PRNewswire/ -- Fish & Richardson has been named the 2020 Intellectual Property Boutique Firm of the Year by LMG Life Sciences. Fish was also awarded the Hatch-Waxman…
Continue Reading »
Massachusetts

Sun Life engages with NAACP Legal Defense Fund and the Smithsonian National Museum of African American History & Culture to support voter and educational initiatives

WELLESLEY, Mass., Sept. 24, 2020 /PRNewswire/ -- As part of Sun Life's larger global efforts to combat racism and support organizations actively fighting for equality, Sun Life will be working with…
Continue Reading »